RED TERAV - Investigadores

Investigadores

Instituto de Investigación Sanitaria Hospital Universitario Puerta de Hierro (IDIPHIM). Madrid.

Terapia de células somáticas y medicina regenerativa

Desarrollos Tecnológicos y Terapéuticos

Investigadores
Publicaciones

cristina Avendaño Solá

Investigador principal

Grupo de Investigación: Instituto de Investigación Sanitaria Hospital Universitario Puerta de Hierro (IDIPHIM). Madrid.

Mercedes Zurita Castillo

Investigador principal

Grupo de Investigación: Instituto de Investigación Sanitaria Hospital Universitario Puerta de Hierro (IDIPHIM). Madrid.

Martínez-Muñoz M.E., Payares-Herrera C., Lipperheide I., Malo de Molina R., Salcedo I., Alonso R., Martín-Donaire T., Sánchez R., Zafra R., García-Berciano M., Trisán-Alonso A., Pérez-Torres M., Ramos-Martínez A., Ussetti P., Rubio J.J., Avendaño-Solà C., Duarte R.F.. Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial. Bone Marrow Transplantation. June 2024. DOI: 10.1038/s41409-024-02230-5.

Impacto: 4.5. Cuartil: Q1

Gómez-Outes A., Sancho-López A., Carcas Sansuan A.J., Avendaño-Solá C.. Clinical research and drug regulation in the challenging times of individualized therapies: A pivotal role of clinical pharmacology. Pharmacological Research. January 2024. DOI: 10.1016/j.phrs.2023.107045.

Impacto: 9.1. Cuartil: Q1 (1er decil)

Romera Martínez I., Avendaño-Solá C., Villegas Da Ros C., Bosch Llobet A., García Erce J.A., González Fraile M.I., Guerra Domínguez L., Vicuña Andrés I., Anguita Velasco J., González Rodríguez V.P., Contreras E., Urcelay Uranga S., Pajares Herraiz Á.L., Jimenez-Marco T., Ojea Pérez A.M., Arroyo Rodríguez J.L., Pérez-Olmeda M., Ramos-Martínez A., Velasco-Iglesias A., Bueno Cabrera J.L., Duarte R.F.. Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial. Vox Sanguinis. January 2024. DOI: 10.1111/vox.13561.

Impacto: 1.8. Cuartil: Q3

Santucci C., López-Valcarcel B.G., Avendaño-Solá C., Bautista M.C., Pino C.G., García L.L., Martín-Perez E., López P.G.. Gender inequity in the medical profession: the women doctors in Spain (WOMEDS) study. Human Resources for Health. December 2023. DOI: 10.1186/s12960-023-00860-2.

Impacto: 3.9. Cuartil: Q1 (1er decil)

Sancho-López A., Ruiz-Antorán B., Iglesias Hernangómez T., Ramírez-García A., Gómez-Estévez I., Sanabria-Cabrera J., Llop Rius R., Pedrós C., Campodonico D., Jiménez-Jorge S., García Luque A., Costa Frossad França L., Montané E., Aldea-Perona A., Téllez Lara N., Bosch Ferrer M., Rodriguez Jiménez C., Bonilla-Toyos E., Sabín Muñoz J., Avendaño-Solá C., Blasco Quilez M.R.. The Need for the Closer Monitoring of Novel Drugs in MS: A Siponimod Retrospective Cohort Study (Realhes Study). Journal of Clinical Medicine. October 2023. DOI: 10.3390/jcm12206471.

Impacto: 3.0. Cuartil: Q1

Caballero-Bermejo A.F., Darnaude-Ximénez I., Aguilar-Pérez M., Gomez-Lopez A., Sancho-López A., López García-Gallo C., Nuevo G.D., Diago-Sempere E., Ruiz-Antorán B., Avendaño-Solá C., Ussetti-Gil P.. Bronchopulmonary penetration of isavuconazole in lung transplant recipients. Antimicrobial Agents and Chemotherapy. October 2023. DOI: 10.1128/aac.00613-23.

Impacto: 4.1. Cuartil: Q1

Sánchez-Guijo F., Avendaño-Solá C., Badimón L., Bueren J.A., Canals J.M., Delgadillo J., Delgado J., Eguizábal C., Fernández-Santos M.E., García-Olmo D., González-Aseguinolaza G., Juan M., Martín F., Mata R., Montserrat N., Pérez-Martínez A., Pérez-Simón J.A., Prósper F., Urbano-Ispizua Á., Zapata A.G., Sureda A., Moraleda J.M.. Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV). Bone Marrow Transplantation. June 2023. DOI: 10.1038/s41409-023-01962-0.

Impacto: 4.5. Cuartil: Q1

Romera Martínez I., Bueno Cabrera J.L., Domingo-Morera J.M., López Aguilar J.C., Villegas Da Ros C., García Erce J.A., Sáez Serrano I., Flores Ballester E., Maglio L.A., Arbona Castaño C., Sola Lapeña C., Guerra Domínguez L., Berberana Fernández M., Madrigal Sánchez M.E., Rubio Batllés M., Pérez-Olmeda M., Ramos-Martínez A., Velasco-Iglesias A., Avendaño-Solá C., Duarte R.F.. Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID-19 convalescent plasma. Vox Sanguinis. April 2023. DOI: 10.1111/vox.13406.

Impacto: 1.8. Cuartil: Q3

García-Pérez J., Bermejo M., Ramírez-García A., De La Torre-Tarazona H.E., Cascajero A., Castillo de la Osa M., Jiménez P., Aparicio Gómez M., Calonge E., Sancho-López A., Payares-Herrera C., Layunta Acero R., Vicente-Izquierdo L., Avendaño-Solá C., Alcamí J., Pérez-Olmeda M., Díez-Fuertes F.. Longer intervals between SARS-CoV-2 infection and mRNA-1273 doses improve the neutralization of different variants of concern. Journal of Medical Virology. March 2023. DOI: 10.1002/jmv.28679.

Impacto: 6.8. Cuartil: Q1 (1er decil)

Durand-Zaleski I., Ducrocq G., Mimouni M., Frenkiel J., Avendano-Solá C., Gonzalez-Juanatey J.R., Ferrari E., Lemesle G., Puymirat E., Berard L., Cachanado M., Arnaiz J.A., Martínez-Sellés M., Silvain J., Ariza-Solé A., Calvo G., Danchin N., Paco S., Drouet E., Abergel H., Rousseau A., Simon T., Gabriel Steg P.. Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost–effectiveness and cost–utility analyses. European Heart Journal - Quality of Care and Clinical Outcomes. 1 March 2023. DOI: 10.1093/ehjqcco/qcac029.

Impacto: 4.8. Cuartil: Q1

Darnaude-Ximénez I., Caballero-Bermejo A.F., Ruiz-Antorán B., Aguilar-Pérez M., Gómez-López A., Sancho-López A., García-Fadul C., Diago-Sempere E., Falcones M.V., Ussetti-Gil P., Avendaño-Solá C.. Bronchopulmonary Penetration of Isavuconazole in Pulmonary Transplant Recipients (PBISA01): Protocol for a Phase IV Clinical Trial With a Single Treatment Arm. JMIR Research Protocols. 1 September 2022. DOI: 10.2196/37275.

Gonzalez-Juanatey J.R., Lemesle G., Puymirat E., Ducrocq G., Cachanado M., Arnaiz J.A., Martínez-Sellés M., Silvain J., Ariza-Solé A., Ferrari E., Calvo G., Danchin N., Avendano-Solá C., Rousseau A., Vicaut E., Gonzalez-Ferrero T., Steg P.G., Simon T.. One-Year Major Cardiovascular Events after Restrictive Versus Liberal Blood Transfusion Strategy in Patients with Acute Myocardial Infarction and Anemia: The REALITY Randomized Trial. Circulation. 8 February 2022. DOI: 10.1161/CIRCULATIONAHA.121.057909.

Impacto: 37.8. Cuartil: Q1 (1er decil)

Park H., Tarpey T., Liu M., Goldfeld K., Wu Y., Wu D., Li Y., Zhang J., Ganguly D., Ray Y., Paul S.R., Bhattacharya P., Belov A., Huang Y., Villa C., Forshee R., Verdun N.C., Yoon H.A., Agarwal A., Simonovich V.A., Scibona P., Burgos Pratx L., Belloso W., Avendaño-Solá C., Bar K.J., Duarte R.F., Hsue P.Y., Luetkemeyer A.F., Meyfroidt G., Nicola A.M., Mukherjee A., Ortigoza M.B., Pirofski L.A., Rijnders B.J.A., Troxel A., Antman E.M., Petkova E.. Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma. JAMA network open. 4 January 2022. DOI: 10.1001/jamanetworkopen.2021.47375.

Impacto: 13.8. Cuartil: Q1 (1er decil)

Troxel A.B., Petkova E., Goldfeld K., Liu M., Tarpey T., Wu Y., Wu D., Agarwal A., Avendaño-Solá C., Bainbridge E., Bar K.J., Devos T., Duarte R.F., Gharbharan A., Hsue P.Y., Kumar G., Luetkemeyer A.F., Meyfroidt G., Nicola A.M., Mukherjee A., Ortigoza M.B., Pirofski L.A., Rijnders B.J.A., Rokx C., Sancho-Lopez A., Shaw P., Tebas P., Yoon H.A., Grudzen C., Hochman J., Antman E.M.. Association of Convalescent Plasma Treatment with Clinical Status in Patients Hospitalized with COVID-19: A Meta-analysis. JAMA Network Open. 2022. DOI: 10.1001/jamanetworkopen.2021.47331.

Impacto: 13.8. Cuartil: Q1 (1er decil)

Sancho-López A., Caballero-Bermejo A.F., Ruiz-Antorán B., Múñez Rubio E., García Gasalla M., Buades J., González Rozas M., López Veloso M., Muñoz Gómez A., Cuenca Abarca A., Durán del Campo P., Ibáñez F., Díaz de Santiago A., Romero Y., Calderón J., Pintos I., Ferre Beltrán A., Centeno Soto G., Campos J., Ramos Martínez A., Avendaño-Solá C., Fernández Cruz A., Caballero A.F.B., Múñez E., Diago-Sempere E., del Campo P.D., de Santiago A.D., Parra J.C., Pinto I., Centeno G., Payares C., Ramírez-García A., Javaloyes L., de la Encina Higuera M., Acero R.L., Vicente L., Araque P.R., Ussetti-Gil P., de Molina R.M., Alonso A.T., Falconés M.V., Montoya F., JiménezJiménez M.L., Ferrer L., Ramos J., Junco A., Díaz A.C., de la Fuente Moral S., Laguna P., Contreras G.V., Serrano A.M., Pérez I.B., Torres-Concha V.M., Maroto A.Á.M., Hernández E.M., Saíz M.C.M., Hernández M.C.C., de Benito R.M., Pita S.M., de Ureta P.T., Pérez M.A., Nuevo G.D., Fadul C.G., Chinarro B.J., Hernández R.L., de la FuenteCarrasco M.L., Gallo C.L.G., Clemente P.M., Arca R.C., IribarrenIribarren M.E., Eisenhofer A.A., Yagüe I.D., VelascoVelasco I.D., López G.E., Palomo E.E., Gómez A.G., Prieto S.G., Irusta J.G., Abreu E.V.G., Martín I.G., Rojas Á.G., Villanueva A.G., Jiménez J.H., Urbistondo M.M., Vara F.M., Sánchez P.M., Vargas A.M., de la Torre I.M., Chica E.S., Alijo Á.V., Comendador J.M.V., Milla A.A., Núñez J.A.V., Martínez V.C.M., Cubero C., Olleros C.R., Carral E.R., Tung Y.. Efficacy and Safety of Sarilumab in patients with COVID19 Pneumonia: A Randomized, Phase III Clinical Trial (SARTRE Study). Infectious Diseases and Therapy. December 2021. DOI: 10.1007/s40121-021-00543-2.

Impacto: 6.119. Cuartil: Q2

Diago-Sempere E., Bueno J.L., Sancho-López A., Rubio E.M., Torres F., de Molina R.M., Fernández-Cruz A., de Diego I.S., Velasco-Iglesias A., Payares-Herrera C., Flecha I.C., Avendaño-Solà C., Palomino R.D., Ramos-Martínez A., Ruiz-Antorán B.. Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial. Trials. December 2021. DOI: 10.1186/s13063-020-05011-9.

Impacto: 2.728. Cuartil: Q4

Payares-Herrera C., Martínez-Muñoz M.E., Vallhonrat I.L., de Molina R.M., Torres M.P., Trisan A., de Diego I.S., Alonso R., Zafra R., Donaire T., Sánchez R., Rubio J.J., Duarte Palomino R.F., Solá C.A.. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial. Trials. December 2021. DOI: 10.1186/s13063-020-04964-1.

Impacto: 2.728. Cuartil: Q4

Huerta A., Caballero Bermejo A.F., de Villa L.F., Sedano R., Ruiz-Antorán B., Avendaño-Solá C., Portoles Pérez J., Sancho-López A.. Measurement of the passage of mycophenolic acid into breast milk in a patient with lupus nephritis. Kidney International. September 2021. DOI: 10.1016/j.kint.2021.05.010.

Impacto: 18.998. Cuartil: Q1 (1er decil)

Bonilla C., Zurita M.. Cell-based therapies for traumatic brain injury: Therapeutic treatments and clinical trials. Biomedicines. June 2021. DOI: 10.3390/biomedicines9060669.

Impacto: 4.757. Cuartil: Q2

Fernández-Cruz A., Ruiz-Antorán B., Múñez-Rubio E., Sancho-López A., Callejas-Díaz A., Avendaño-Solá C., Ramos-Martínez A.. The Right Time for Steroids in COVID-19. Clinical Infectious Diseases. 15 April 2021. DOI: 10.1093/cid/ciaa865.

Impacto: 20.999. Cuartil: Q1 (1er decil)

Ruiz-Antorán B., Sancho-López A., Torres F., Moreno-Torres V., de Pablo-López I., García-López P., Abad-Santos F., Rosso-Fernández C.M., Aldea-Perona A., Montané E., Aparicio-Hernández R.M., Llop-Rius R., Pedrós C., Gijón P., Hernández-Carballo C., Pedrosa-Martínez M.J., Rodríguez-Jiménez C., Prada-Ramallal G., Cabrera-García L., Aguilar-García J.A., Sanjuan-Jimenez R., Ortiz-Barraza E.I., Sánchez-Chica E., Fernández-Cruz A., Sala X.F., Pellicer P.D., Cerrato S.G., Anillo J.M.D., Palacios A.R., Cubiles E., Acosta M.Á.L., Gutierrez R.F., Candón A.M., Alejandre S.S., Herreros J.M.C., Matía E.C., Dominguez C.I., Rivas J.C.C., Verdugo M.L., Toste I.S., Pérez P.D., Villero F.M., Cuartin G.S., Gonzalez C.G., Fuster A.I., Galmes M.G., Pérez S., Cumplido D.R., de León Gil A., Sanz E.J., Sanz-Herrero F., Puchades F., Ortega-García P., Díaz-Peromingo J.A., Rodríguez-Moreno C., Lozano D., Terleira A., Castro M.E.G., Murcia S.F., Aguilera E.M.G., Pintos-Sanchez E., Zubiaur P., Santos-Molina E., Navares-Gómez M., Abril G.M., García-Luque A., Puerro-Vicente M., Carrillo M.J.S., Múgica M.Á.G., Jiménez M.A., Díaz C.S., Solá C.A., Mills-Sánchez P., Valle M., Centeno G., Payares C., Bermejo A.F.C., Diago E., de Molina R.M., Nuñez J.A.V., Muñez E., Ramos A., Barriocanal A.M., Pérez-Acevedoc A.P., Núñez-Montero M., Olmedo M., De la Villa S., Álvarez E.N., Lucena M.I., García J.A.A., Alegría J.J.G.. Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study. Infectious Diseases and Therapy. March 2021. DOI: 10.1007/s40121-020-00373-8.

Impacto: 6.119. Cuartil: Q2

Ducrocq G., Gonzalez-Juanatey J.R., Puymirat E., Lemesle G., Cachanado M., Durand-Zaleski I., Arnaiz J.A., Martínez-Sellés M., Silvain J., Ariza-Solé A., Ferrari E., Calvo G., Danchin N., Avendaño-Solá C., Frenkiel J., Rousseau A., Vicaut E., Simon T., Steg P.G.. Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events among Patients with Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial. JAMA - Journal of the American Medical Association. 9 February 2021. DOI: 10.1001/jama.2021.0135.

Impacto: 157.335. Cuartil: Q1 (1er decil)

Ducrocq G., Calvo G., González-Juanatey J.R., Durand-Zaleski I., Avendano-Sola C., Puymirat E., Lemesle G., Arnaiz J.A., Martínez-Sellés M., Rousseau A., Cachanado M., Vicaut E., Silvain J., Karam C., Danchin N., Simon T., Steg P.G.. Restrictive vs liberal red blood cell transfusion strategies in patients with acute myocardial infarction and anemia: Rationale and design of the REALITY trial. Clinical Cardiology. February 2021. DOI: 10.1002/clc.23453.

Impacto: 3.287. Cuartil: Q3

Avendaño-Solá C., Ramos-Martínez A., Muñez-Rubio E., Ruiz-Antorán B., De Molina R.M., Torres F., Fernández-Cruz A., Calderón-Parra J., Payares-Herrera C., De Santiago A.D., Romera-Martínez I., Pintos I., Lora-Tamayo J., Mancheño-Losa M., Paciello M.L., Martínez-González A.L., Vidán-Estévez J., Nuñez-Orantos M.J., Saez-Serrano M.I., Porras-Leal M.L., Jarilla-Fernández M.C., Villares P., De Oteyza J.P., Ramos-Garrido A., Blanco L., Madrigal-Sánchez M.E., Rubio-Batllés M., Velasco-Iglesias A., Paño-Pardo J.R., Moreno-Chulilla J.A., Muñiz-Díaz E., Casas-Flecha I., Pérez-Olmeda M., García-Pérez J., Alcamí J., Bueno J.L., Duarte R.F.. A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia. Journal of Clinical Investigation. 2021. DOI: 10.1172/JCI152740.

Impacto: 19.456. Cuartil: Q1 (1er decil)

Gómez-Barrena E., Padilla-Eguiluz N.G., Rosset P., Hernigou P., Baldini N., Ciapetti G., Gonzalo-Daganzo R.M., Avendaño-Solá C., Rouard H., Giordano R., Dominici M., Schrezenmeier H., Layrolle P.. Osteonecrosis of the femoral head safely healed with autologous, expanded, bone marrow-derived mesenchymal stromal cells in a multicentric trial with minimum 5 years follow-up. Journal of Clinical Medicine. 2021. DOI: 10.3390/jcm10030508.

Impacto: 4.964. Cuartil: Q2

Lopez-Pajaro L.F., Ruiz-Antoran B., Marin-Serrano E., Cazorla-Calleja R., Iglesias-Escalera G., Lara-Herguedas J., Garcia-Merino J.A., Avendano-Sola C., Sancho-Lopez A.. Descriptive analysis of the electroencephalogram in Angelman syndrome. Revista de Neurologia. 2021. DOI: 10.33588/RN.7202.2020548.

Impacto: 1.235. Cuartil: Q4

Caballero Bermejo A.F., Ruiz-Antorán B., Fernández Cruz A., Diago Sempere E., Callejas Díaz A., Múñez Rubio E., Avendaño-Solá C., Ramos Martínez A., Sancho López A.. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial. Trials. 16 September 2020. DOI: 10.1186/s13063-020-04633-3.

Impacto: 2.279. Cuartil: Q4

Fernández-Cruz A., Ruiz-Antorán B., Muñoz-Gómez A., Sancho-López A., Mills-Sánchez P., Centeno-Soto G.A., Blanco-Alonso S., Galán-Gómez A., Valencia-Alijo Á., Gómez-Irusta J., Payares-Herrera C., Morrás-Torre I., Sánchez-Chica E., Delgado-Téllez-de-Cepeda L., Callejas-Díaz A., Ramos-Martínez A., Múñez-Rubio E., Avendaño-Solá C., Malo de Molina Ruiz R., Pintos Pascual I., Díaz De Santiago A., de la Fuente Moral S., Laguna Del Estal P., Vázquez Contreras G., Valle Falcones M., Muñoz Serrano A., Cantos Sánchez De Ibarguen B., Calderón Parra J., Ángel-Moreno Maroto A., Baños Pérez I., Máinez Sáiz M.C., Montero Hernández E., Moreno-Torres Concha V., Carreño Hernández M.C., Romero Pizarro Y., Muñoz De Benito R., Durán Del Campo P., Mellor Pita S., Tutor De Ureta P., Aguilar Pérez M., Díaz Nuevo G.G., García Fadul C., Jara Chinarro B., Laporta Hernández R., Lázaro Carrasco de la Fuente M.T., López García Gallo C.M., Mínguez Clemente P., Trisán Alonso A., Carabias Arca R., Erro Iribarren M., Agudo Castillo B., Aller Pardo J., Balandín Moreno B., Benlloch Rodríguez R., Blasco Quílez M.R., Brito Sanfiel M.Á., Calvo De Juan V., Calvo Moya M., Campos Esteban J., Cazorla Calleja R., Cea Soriano M., Cembrero Saralegui H., Colino Alcol E., Córdoba Largo S., Cruz Melguizo S., Del Pozo Jiménez G., Del Pozo Martín C., Elosua González M., Espinosa Malpartida M., Fernández Manzano C., Ferre Aracil C., García-Espantaleón Navas M., García-Izquierdo Jaén E.A., Gil Haro B., Gómez-Porro Sánchez P., González López S., González Partida I., Hernández López R., Hernández Pérez F.J., Huerta Arroyo A.M., Iglesias Escalera G., López Llorca A.I., Javaloyes-Garachana L., Marín Martínez M.E., Martínez Badas I., Martínez Muñoz M.E., Maximiano Alonso C.S., Méndez García M., Mingo Santos S., Mitroi C., Núñez García B., Ortega García P., Ortega López A., Oteo Domínguez J.F., Pérez Fernández N., Prieto Coca L., Relea Pérez L., Rodríguez Reina G.. A retrospective controlled cohort study of the impact of glucocorticoid treatment in SARS-CoV-2 infection mortality. Antimicrobial Agents and Chemotherapy. 01 September 2020. DOI: 10.1128/AAC.01168-20.

Impacto: 5.191. Cuartil: Q1

Gómez-Barrena E., Padilla-Eguiluz N., Rosset P., Gebhard F., Hernigou P., Baldini N., Rouard H., Sensebé L., Gonzalo-Daganzo R.M., Giordano R., García-Rey E., Cordero-Ampuero J., Rubio-Suárez J.C., García-Simón M.D., Stanovici J., Ehrnthaller C., Huber-Lang M., Flouzat-Lachaniette C.H., Chevallier N., Donati D.M., Spazzoli B., Ciapetti G., Fleury S., Fernandez M.N., Cabrera J.R., Avendaño-Solá C., Montemurro T., Panaitescu C., Veronesi E., Rojewski M.T., Lotfi R., Dominici M., Schrezenmeier H., Layrolle P.. Early efficacy evaluation of mesenchymal stromal cells (MSC) combined to biomaterials to treat long bone non-unions. Injury. April 2020. DOI: 10.1016/j.injury.2020.02.070.

Impacto: 2.586. Cuartil: Q2

Gómez de Antonio D., Campo-Cañaveral de la Cruz J.L., Zurita M., Santos M., González Lois C., Varela de Ugarte A., Vaquero J.. Bone Marrow-derived Mesenchymal Stem Cells and Chronic Allograft Disease in a Bronchiolitis Obliterans Animal Model. Archivos de Bronconeumologia. March 2020. DOI: 10.1016/j.arbres.2019.05.016.

Impacto: 4.872. Cuartil: Q2

Dal-Ré R., Avendaño-Solà C., de Boer A., James S.K., Rosendaal F.R., Stephens R., Ioannidis J.P.A.. A limited number of medicines pragmatic trials had potential for waived informed consent following the 2016 CIOMS ethical guidelines. Journal of Clinical Epidemiology. October 2019. DOI: 10.1016/j.jclinepi.2019.06.007.

Impacto: 4.952. Cuartil: Q1 (1er decil)

VAQUERO J., ZURITA M., MUCIENTES J., PASCUAL M.L., FERNÁNDEZ-MATEOS C., GARCIA E., FERNÁNDEZ-GUINEA S.A.R.A.. Intrathecal cell therapy with autologous stromal cells increases cerebral glucose metabolism and can offer a new approach to the treatment of Alzheimer's type dementia. Cytotherapy. April 2019. DOI: 10.1016/j.jcyt.2019.02.009.

Impacto: 4.218. Cuartil: Q1

Gómez-Barrena E., Rosset P., Gebhard F., Hernigou P., Baldini N., Rouard H., Sensebé L., Gonzalo-Daganzo R.M., Giordano R., Padilla-Eguiluz N., García-Rey E., Cordero-Ampuero J., Rubio-Suárez J.C., Stanovici J., Ehrnthaller C., Huber-Lang M., Flouzat-Lachaniette C.H., Chevallier N., Donati D.M., Ciapetti G., Fleury S., Fernandez M.N., Cabrera J.R., Avendaño-Solá C., Montemurro T., Panaitescu C., Veronesi E., Rojewski M.T., Lotfi R., Dominici M., Schrezenmeier H., Layrolle P.. Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial. Biomaterials. March 2019. DOI: 10.1016/j.biomaterials.2018.03.033.

Impacto: 10.317. Cuartil: Q1 (1er decil)

Dal-Ré R., Abad-Santos F., Avendaño-Solà C.. Modifications and waivers of informed consent and the Council for International Organizations of Medical Sciences guidelines. Medicina Clinica. 18 January 2019. DOI: 10.1016/j.medcli.2018.04.013.

Impacto: 1.635. Cuartil: Q3

Gratacós J., Pontes C., Juanola X., Sanz J., Torres F., Avendaño C., Vallano A., Calvo G., De Miguel E., Sanmartí R., Almirall M., Aparicio M., Sellas A., Vives R., Albiñana N., Moreno M., Clavaguera T., Torre-Alonso J.C., Veroz R., Rodríguez-Lozano C., Linares L.F., Urruticoechea A., Collantes E., Morlà R.M., Reina D., Cuende E., Zarco P., Fernández-Espartero M.C., García-Vicuña R., Montilla C.A., Villalba A., Pascual D., Campos C., Juan A., Ariza R., Díaz-Miguel C., Maqueda M., Fernández-Dapica M.P., Fernández-Prada M., Batlle E., González-Fernández C., Queiro R.. Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis. Arthritis Research and Therapy. 8 January 2019. DOI: 10.1186/s13075-018-1772-z.

Impacto: 4.103. Cuartil: Q1

Dal-Ré R., Avendaño-Solà C., Bloechl-Daum B., De Boer A., Eriksson S., Fuhr U., Holm S., James S.K., Mentz R.J., Perucca E., Rosendaal F.R., Treweek S.. Low risk pragmatic trials do not always require participants' informed consent. The BMJ. 2019. DOI: 10.1136/bmj.l1092.

Impacto: 30.313. Cuartil: Q1 (1er decil)

Micó-Pérez R.M., Payares-Herrera C., Palomo-Jiménez P.I., Sánchez-Fierro J., Avendaño-Solá C., Llisterri-Caro J.L.. Knowledge about Biosimilars in Primary Care: a study by the Spanish Society of Primary Care Physicians (SEMERGEN). Semergen. September 2018. DOI: 10.1016/j.semerg.2018.01.002.

Ruiz-Antoran B., Sancho-López A., Cazorla-Calleja R., López-Pájaro L.F., Leiva Á., Iglesias-Escalera G., Marín-Serrano M.E., Rincón-Ortega M., Lara-Herguedas J., Rossignoli-Palomeque T., Valiente-Rodríguez S., González-Marques J., Román-Riechmann E., Avendaño-Solá C.. A randomized placebo controlled clinical trial to evaluate the efficacy and safety of minocycline in patients with Angelman syndrome (A-MANECE study). Orphanet Journal of Rare Diseases. 20 August 2018. DOI: 10.1186/s13023-018-0891-6.

Impacto: 3.687. Cuartil: Q2

Vaquero J., Zurita M., Rico M.A., Aguayo C., Bonilla C., Marin E., Tapiador N., Sevilla M., Vazquez D., Carballido J., Fernandez C., Rodriguez-Boto G., Ovejero M., Rodríguez A., Martínez P., de la Calle S., Fernández M.V., de Reina L., Saab A., Cotua C., Santander X.A., Gutiérrez R., Saldaña C., Hassan R., Ortega C., Madrid A., Mariscal M., López L.F., Pérez A., Ebrat E.E., Vaquero M., Martín M., Mayoral I., Canales D., Carballido J., Serrano R., Saucedo G., Cabrera R., Begoña Pérez de Camino M.E.M., Alarcón A., Naya D., Alonso R., Alamo J.R., Romera I., Mourelle I., Sánchez C., Segovia R., Gutiérrez A., Guillo V., del Valle S., Rey P., Mucientes J., Rodríguez B.. Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline. Cytotherapy. June 2018. DOI: 10.1016/j.jcyt.2018.03.032.

Impacto: 4.297. Cuartil: Q1

Vaquero J., Zurita M., Rico M.A., Aguayo C., Fernandez C., Rodriguez-Boto G., Marin E., Tapiador N., Sevilla M., Carballido J., Vazquez D., Garcia-Olmo D., Guadalajara H., Leon M., Valverde I.. Cell therapy with autologous mesenchymal stromal cells in post-traumatic syringomyelia. Cytotherapy. June 2018. DOI: 10.1016/j.jcyt.2018.04.006.

Impacto: 4.297. Cuartil: Q1

Vaquero J., Zurita M., Rico M.A., Aguayo C., Fernández C., Gutiérrez R., Rodríguez-Boto G., Saab A., Hassan R., Ortega C.. Intrathecal administration of autologous bone marrow stromal cells improves neuropathic pain in patients with spinal cord injury. Neuroscience Letters. 23 March 2018. DOI: 10.1016/j.neulet.2018.01.035.

Impacto: 2.173. Cuartil: Q3

Cruz-Melguizo S., San-Frutos L., Martínez-Payo C., Ruiz-Antorán B., Adiego-Burgos B., Campillos-Maza J.M., García-González C., Martínez-Guisasola J., Pérez-Carbajo E., Teulón-González M., Avendaño-Solá C., Pérez-Medina T.. Cervical pessary compared with vaginal progesterone for preventing early preterm birth a randomized controlled trial. Obstetrics and Gynecology. 2018. DOI: 10.1097/AOG.0000000000002884.

Impacto: 4.965. Cuartil: Q1 (1er decil)

Vaquero J., Hassan R., Fernández C., Rodríguez-Boto G., Zurita M.. Cell Therapy as a New Approach to the Treatment of Posttraumatic Syringomyelia. World Neurosurgery. November 2017. DOI: 10.1016/j.wneu.2017.08.019.

Impacto: 1.924. Cuartil: Q2

Vaquero J., Zurita M., Rico M.A., Bonilla C., Aguayo C., Fernández C., Tapiador N., Sevilla M., Morejón C., Montilla J., Martínez F., Marín E., Bustamante S., Vázquez D., Carballido J., Rodríguez A., Martínez P., García C., Ovejero M., Fernández M.V.. Repeated subarachnoid administrations of autologous mesenchymal stromal cells supported in autologous plasma improve quality of life in patients suffering incomplete spinal cord injury. Cytotherapy. 1 March 2017. DOI: 10.1016/j.jcyt.2016.12.002.

Impacto: 3.993. Cuartil: Q1

Palanca-Maresca I., Ruiz-Antorán B., Centeno-Soto G.A., Forti-Buratti M.A., Siles A., Usano A., Avendanõ-Solá C.. Prevalence and Risk Factors of Prolonged Corrected QT Interval among Children and Adolescents Treated with Antipsychotic Medications: A Long-Term Follow-Up in a Real-World Population. Journal of Clinical Psychopharmacology. 1 February 2017. DOI: 10.1097/JCP.0000000000000639.

Impacto: 3.134. Cuartil: Q2

Sacristán J.A., Dilla T., Garrido P., Avendaño C., Cruz-Hernández J.J., Espinosa J., Comellas M., Lizán L.. Should clinically meaningful outcomes in cancer be based on individual survival rather than median overall survival?. Future Virology. 2017. DOI: 10.2217/cer-2016-0081.

Impacto: 1.121. Cuartil: Q4

Vaquero J., Zurita M., Bonilla C., Fernández C., Rubio J., Mucientes J., Rodriguez B., Blanco E., Donis L.. Progressive increase in brain glucose metabolism after intrathecal administration of autologous mesenchymal stromal cells in patients with diffuse axonal injury. Cytotherapy. 1 January 2017. DOI: 10.1016/j.jcyt.2016.10.001.

Impacto: 3.993. Cuartil: Q1

Vaquero J., Zurita M., Fernández C., Cotua C.. Inexpensive Attachment Device for Cell Therapy Administration into Injured Spinal Cord. World Neurosurgery. 1 December 2016. DOI: 10.1016/j.wneu.2016.09.060.

Impacto: 2.592. Cuartil: Q2

Sacristán J.A., Lizan L., Comellas M., Garrido P., Avendaño C., Cruz-Hernández J.J., Espinosa J., Dilla T.. Perceptions of Oncologists, Healthcare Policy Makers, Patients and the General Population on the Value of Pharmaceutical Treatments in Oncology. Advances in Therapy. 1 November 2016. DOI: 10.1007/s12325-016-0415-5.

Impacto: 2.709. Cuartil: Q2

Sáez-Peñataro J., Avendaño-Solá C., González-Juanatey J.R.. Clinical considerations on the posology of direct oral anticoagulants. Revista Clinica Espanola. 1 October 2016. DOI: 10.1016/j.rce.2016.04.010.

Impacto: 0.971. Cuartil: Q3

Vaquero J., Zurita M., Rico M.A., Bonilla C., Aguayo C., Montilla J., Bustamante S., Carballido J., Marin E., Martinez F., Parajon A., Fernandez C., Reina L.D.. An approach to personalized cell therapy in chronic complete paraplegia: The Puerta de Hierro phase I/II clinical trial. Cytotherapy. 1 August 2016. DOI: 10.1016/j.jcyt.2016.05.003.

Impacto: 3.203. Cuartil: Q2

Sacristán J.A., Aguarón A., Avendaño-Solá C., Garrido P., Carrión J., Gutiérrez A., Kroes R., Flores A.. Patient involvement in clinical research: Why, when, and how. Patient Preference and Adherence. 27 April 2016. DOI: 10.2147/PPA.S104259.

Impacto: 1.798. Cuartil: Q2

Martínez-Salamanca J.I., Zurita M., Costa C., Martínez-Salamanca E., Fernández A., Castela A., Vaquero J., Carballido J., Angulo J.. Dual Strategy With Oral Phosphodiesterase Type 5 Inhibition and Intracavernosal Implantation of Mesenchymal Stem Cells Is Superior to Individual Approaches in the Recovery of Erectile and Cavernosal Functions After Cavernous Nerve Injury in Rats. Journal of Sexual Medicine. 2016. DOI: 10.1016/j.jsxm.2015.12.001.

Impacto: 2.978. Cuartil: Q2

Annese V., Avendaño-Solá C., Breedveld F., Ekman N., Giezen T.J., Gomollón F., Kurki P., Kvien T.K., Laslop A., Puig L., Thorpe R., Weise M., Wolff-Holz E.. Roundtable on biosimilars with European regulators and medical societies, Brussels, Belgium, 12 January 2016. GaBI Journal. 2016. DOI: 10.5639/gabij.2016.0502.019.

Dilla T., Lizan L., Paz S., Garrido P., Avendaño C., Cruz-Hernández J.J., Espinosa J., Sacristán J.A.. Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population. Patient Preference and Adherence. 18 December 2015. DOI: 10.2147/PPA.S93760.

Impacto: 1.718. Cuartil: Q2

Cabrera-García L., Cruz-Melguizo S., Ruiz-Antorán B., Torres F., Velasco A., Martínez-Payo C., Avendaño-Solá C., Melguizo S.C., Cordero E., Burgos B.A., Guisasola J.M., Cortés L.M., González C.G., Segura G.Q., Abarca L., Savirón R., Carbajo E.P., Rodríguez León J.A., Bartha J.L., Teulón M., Nogales R., Rodríguez , Alonso G., Colomo C.Á., Anaya Baz M., Davó D.A., Cancelo M.J., De Teran E.M.D., Mateu Pruñunosa J.C., Gálvez G., Torre A., Marqueta Sánchez J.M., Bermejo R., Artola A.L., Rodríguez E.C., deDios E.. Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): Study protocol for a randomized controlled trial. Trials. 25 September 2015. DOI: 10.1186/s13063-015-0964-y.

Impacto: 1.859. Cuartil: Q3

Pontes C., Gratacós J., Torres F., Avendaño C., Sanz J., Vallano A., Juanola X., Miguel E., Sanmartí R., Calvo G.. Evaluation of dose reduction versus standard dosing for maintenance of remission in patients with spondyloarthritis and clinical remission with anti-TNF (REDES-TNF): Study protocol for a randomized controlled trial. Trials. August 20, 2015. DOI: 10.1186/s13063-015-0828-5.

Impacto: 1.859. Cuartil: Q3

Soto G.A.C., Ruiz-Antorán B., Laporta R., Sancho A., Lázaro M.T., Herrera C.P., Salcedo I., Cos M.A., Torres F., Usetti P., Avendaño-Sola C.. Dose increase needed in most cystic fibrosis lung transplantation patients when changing from twice- to once-daily tacrolimus oral administration. European Journal of Clinical Pharmacology. 1 June 2015. DOI: 10.1007/s00228-015-1859-2.

Impacto: 2.71. Cuartil: Q2

Sacristán J.A., Avendaño-Solá C.. On heterogeneity of treatment effects and clinical freedom. International Journal of Clinical Practice. 1 January 2015. DOI: 10.1111/ijcp.12537.

Impacto: 2.226. Cuartil: Q1

Bonilla C., Zurita M., Aguayo C., Rodríguez A., Vaquero J.. Is the subarachnoid administration of mesenchymal stromal cells a useful strategy to treat chronic brain damage?. Cytotherapy. 1 November 2014. DOI: 10.1016/j.jcyt.2014.07.007.

Impacto: 3.293. Cuartil: Q2

Gómez-Outes A., Avendaño-Solá C., Terleira-Fernández A.I., Vargas-Castrillón E.. Pharmacoeconomic Evaluation of Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement in Spain. PharmacoEconomics. 1 September 2014. DOI: 10.1007/s40273-014-0175-5.

Impacto: 2.45. Cuartil: Q1 (1er decil)

Vaquero J., Zurita M., Aguayo C.. Traumatic paraplegia at thoracic level: Long-term morphological alterations in spinal cord. Trauma (Spain). July-September 2014. DOI: .

Gómez-Barrena E., Solá C.A., Bunu C.P.. Regulatory authorities and orthopaedic clinical trials on expanded mesenchymal stem cells. International Orthopaedics. September 2014. DOI: 10.1007/s00264-014-2332-z.

Impacto: 2.11. Cuartil: Q2

Piñeiro Pérez R., Ruiz Antorán M.B., Avendaño Solá C., Román Riechmann E., Cabrera García L., Cilleruelo Ortega M.J., Mellado Peña M.J.. Results from the 2012-2013 paediatric national survey on off-label drug use in children in Spain (OL-PED study). Anales de Pediatria. July 2014. DOI: 10.1016/j.anpedi.2013.10.004.

Impacto: 0.833. Cuartil: Q4

Avendaño-Solá C., Panés J., Calvo G.. Biosimilar therapy for inflammatory bowel disease. Revista Espanola de Enfermedades Digestivas. January 2014. DOI: 10.4321/S1130-01082014000100014.

Impacto: 1.414. Cuartil: Q4

Palanca-Maresca I., Ruiz-Antorán B., Centeno-Soto G., Jiménez-Fernandez S., García-Murillo L., Siles A., Villagrá S., Blasco-Fontecilla H., Iruela-Cuadrado L., Roman-Riechman E., Avendaño-Solá C., Correll C.U.. SENTIA: A systematic online monitoring registry for children and adolescents treated with antipsychotics. SpringerPlus. 2014. DOI: 10.1186/2193-1801-3-187.

Vaquero J., Zurita M.. Cell transplantation in paraplegic patients: The importance of properly assessing the spinal cord morphology. Clinical Transplantation. November 2013. DOI: 10.1111/ctr.12267.

Impacto: 1.486. Cuartil: Q2

Zurita M., Aguayo C., Bonilla C., Rodriguez A., Vaquero J.. Perilesional intrathecal administration of autologous bone marrow stromal cells achieves functional improvement in pigs with chronic paraplegia. Cytotherapy. October 2013. DOI: 10.1016/j.jcyt.2013.05.012.

Impacto: 3.1. Cuartil: Q2

Ruíz-Antorán B., Piñeiro R., Avendaño C., Román E., Cilleruelo M.L., Gutiérrez-Junquera C., Centeno G., Cilleruelo M.J.. Drug utilization and off-label drug use in spanish pediatric gastroenterology outpatients. Journal of Pediatric Gastroenterology and Nutrition. February 2013. DOI: 10.1097/MPG.0b013e3182566d92.

Impacto: 2.873. Cuartil: Q1

Vaquero J., Zurita M.. Ependymoma models. Neuromethods. 2013. DOI: 10.1007/7657_2011_26.

Bonilla C., Zurita M., Otero L., Aguayo C., Rodríguez A., Rico M.A.. Severe disability after traumatic brain injury: Therapeutic posibilities of subarachnoid administration of stromal cells. Trauma (Spain). 2013. DOI: .

Vaquero J., Otero L., Bonilla C., Aguayo C., Rico M.A., Rodriguez A., Zurita M.. Cell therapy with bone marrow stromal cells after intracerebral hemorrhage: Impact of platelet-rich plasma scaffolds. Cytotherapy. January 2013. DOI: 10.1016/j.jcyt.2012.10.005.

Impacto: 3.1. Cuartil: Q2

Vaquero J., Zurita M., Coca S.. Clinical behavior in metastatic brain disease is not influenced by the immunological defense mediated by CD57 <sup>+</sup> NK-cells. International Journal of Surgical Oncology. 2012. DOI: 10.1155/2012/834852.

Zurita M., Aguayo C., Bonilla C., Otero L., Rico M., Rodríguez A., Vaquero J.. The pig model of chronic paraplegia: A challenge for experimental studies in spinal cord injury. Progress in Neurobiology. June 2012. DOI: 10.1016/j.pneurobio.2012.04.005.

Impacto: 9.035. Cuartil: Q1 (1er decil)

Avendaño Solá C., Delgadillo Duarte J., De Abajo F.J., Sanz N.. Changes in the European normative of clinical trials (II): Towards a proportional and risk-adapted regulation. Medicina Clinica. 12 May 2012. DOI: 10.1016/j.medcli.2011.12.010.

Impacto: 1.399. Cuartil: Q2

Bonilla C., Zurita M., Otero L., Aguayo C., Rico M.A., Vaquero J.. The severity of brain damage determines bone marrow stromal cell therapy efficacy in a traumatic brain injury model. Journal of Trauma and Acute Care Surgery. May 2012. DOI: 10.1097/TA.0b013e318248bdcf.

Impacto: 0.0. Cuartil: Q4

Avendaño Solá C., Delgadillo Duarte J., Pontes García C., Cabrera García L.. Changes in the European normative of clinical trials (i): A chance to improve the paperwork authorization. Medicina Clinica. 28 April 2012. DOI: 10.1016/j.medcli.2011.12.008.

Impacto: 1.399. Cuartil: Q2

Bonilla C., Zurita M., Otero L., Aguayo C., Rico M.A., Vaquero J.. Influence of the level of neurological deficit on the efficacy of cell therapy in a model of severe traumatic brain injury. Trauma (Spain). April 2012. DOI: .

Bonilla C., Zurita M., Otero L., Aguayo C., Rico M.A., Vaquero J.. Endogenous neurogenesis after traumatic brain injury and its modulation by cell therapy. Trauma (Spain). April 2012. DOI: .

Bonilla C., Otero L., Vela A., Zurita M., Rico M., Aguayo C., Rodríguez A., Vaquero J.. Traumatic brain injury: Failure of the intravenous route for the administration of bone marrow stromal stem cells as treatment of chronic neurological sequels. Trauma (Spain). April 2012. DOI: .

Otero L., Zurita M., Bonilla C., Rico M.A., Aguayo C., Rodriguez A., Vaquero J.. Endogenous neurogenesis after intracerebral hemorrhage. Histology and Histopathology. March 2012. DOI: .

Impacto: 2.281. Cuartil: Q2

Bonilla C., Zurita M., Otero L., Aguayo C., Rico M.A., Rodríguez A., Vaquero J.. Failure of delayed intravenous administration of bone marrow stromal cells after traumatic brain injury. Journal of Neurotrauma. 20 January 2012. DOI: 10.1089/neu.2011.2101.

Impacto: 4.295. Cuartil: Q1

Otero L., Zurita M., Bonilla C., Aguayo C., Rico M.A., Vaquero J.. Perspectives of cell therapy in sequelae from cerebrovascular accidents. Neurocirugia. September-October 2012. DOI: 10.1016/j.neucir.2011.10.002.

Impacto: 0.343. Cuartil: Q4

Otero L., Zurita M., Bonilla C., Aguayo C., Rico M.A., Rodríguez A., Vaquero J.. Allogeneic bone marrow stromal cell transplantation after cerebral hemorrhage achieves cell transdifferentiation and modulates endogenous neurogenesis. Cytotherapy. January 2012. DOI: 10.3109/14653249.2011.608349.

Impacto: 3.055. Cuartil: Q2

Vaquero J., Zurita M.. Functional recovery after severe CNS trauma: Current perspectives for cell therapy with bone marrow stromal cells. Progress in Neurobiology. March 2011. DOI: 10.1016/j.pneurobio.2010.12.002.

Impacto: 8.874. Cuartil: Q1 (1er decil)

Otero L., Zurita M., Bonilla C., Aguayo C., Vela A., Rico M.A., Vaquero J.. Late transplantation of allogeneic bone marrow stromal cells improves neurologic deficits subsequent to intracerebral hemorrhage. Cytotherapy. May 2011. DOI: 10.3109/14653249.2010.544720.

Impacto: 3.627. Cuartil: Q1

Gomez-De-Antonio D., Zurita M., Santos M., Salas I., Vaquero J., Varela A.. Stem cells and bronchial stump healing. Journal of Thoracic and Cardiovascular Surgery. December 2010. DOI: 10.1016/j.jtcvs.2010.03.009.

Impacto: 3.608. Cuartil: Q1 (1er decil)

Otero L., Zurita M., Aguayo C., Bonilla C., Rodríguez A., Vaquero J.. Video-Tracking-Box linked to Smart software as a tool for evaluation of locomotor activity and orientation in brain-injured rats. Journal of Neuroscience Methods. April 2010. DOI: 10.1016/j.jneumeth.2010.01.036.

Impacto: 2.1. Cuartil: Q3

Otero L., Bonilla C., Aguayo C., Zurita M., Vaquero J.. Intralesional administration of allogeneic bone marrow stromal cells reduces functional deficits after intracerebral hemorrhage. Histology and Histopathology. April 2010. DOI: .

Impacto: 2.502. Cuartil: Q2

Vaquero J., Zurita M.. Mesenchymal stem cells for brain and spinal cord repair. European Journal of Clinical Pharmacology. September 2010. DOI: .

Impacto: 3.032. Cuartil: Q2

Zurita M., Otero L., Aguayo C., Bonilla C., Ferreira E., Parajón A., Vaquero J.. Cell therapy for spinal cord repair: Optimization of biologic scaffolds for survival and neural differentiation of human bone marrow stromal cells. Cytotherapy. July 2010. DOI: 10.3109/14653241003615164.

Impacto: 2.925. Cuartil: Q2

Bonilla Horcajo C., Otero L., Aguayo C., Rodríguez A., Zurita M., Vaquero J.. Cell therapy for treatment of traumatic brain injury: Utility of different tests for functional assessment. Trauma. October 2009. DOI: .

Bonilla Horcajo C., Otero L., Aguayo C., Rodríguez A., Zurita M., Vaquero J.. Study of the usefulness of fibrin gel as a biological scaffold for intracerebral transplantation of mesenchymal stem cells. Trauma. October 2009. DOI: .

Avendaño Solá C.. Compassionate use of off-label drugs: Need for a change in Spain. Medicina Clinica. 26 September 2009. DOI: 10.1016/j.medcli.2009.07.003.

Impacto: 1.231. Cuartil: Q3

Vaquero J., Zurita M.. Bone marrow stromal cells for spinal cord repair: A challenge for contemporary neurobiology. Histology and Histopathology. 2009. DOI: .

Impacto: 2.404. Cuartil: Q2

Bonilla C., Zurita M., Otero L., Aguayo C., Vaquero J.. Delayed intralesional transplantation of bone marrow stromal cells increases endogenous neurogenesis and promotes functional recovery after severe traumatic brain injury. Brain Injury. August 2009. DOI: 10.1080/02699050903133970.

Impacto: 1.533. Cuartil: Q2

Martínez-Silva B., Ferreira E., Martínez V., Otero L., Bonilla C., Aguayo C., Rodríguez A., Martínez-Silva J., Zurita M., Vaquero J.. Perspectives of cell therapy in the ischemic brain injury. Trauma. January 2009. DOI: .

Vaquero J., Bonilla C., Otero L., Aguayo C., Oya S., Zurita M.. Angiogenesis and vasculogenesis induced by intralesional adult mesenchymal stem cell transplantation in an experimental spinal cord injury model. Trauma. October 2008. DOI: .

Vaquero J., Bonilla C., Otero L., Aguayo C., Oya S., Zurita M.. Neural differentiation of human bone marrow stromal cells in the presence of cerebrospinal fluid. Trauma. October 2008. DOI: .

Vaquero J., Bonilla C., Otero L., Aguayo C., Oya S., Zurita M.. Neuroprotector effect of adult mesenchymal stem cells in the early phases after spinal cord injury. Trauma. October 2008. DOI: .